FIELD: medicine.
SUBSTANCE: invention relates to non-steroidal anti-inflammatory drugs application in excimer laser corneal surgery. Stroma ablation is performed after de-epithelized cornea staining with 0.1-1.0% isotonic solution of rose bengal with additional postoperative corneal UV protection by means of sunglasses. This creates a shielding effect for secondary transformed UV radiation (emerging during ablation) penetration in the deeper layers adjacent to the ablation zone. Appointment of corneal sunglasses protection to block external UV rays in the postoperative period contributes as well.
EFFECT: prevention of additional phototoxic products formation from NSAIDs.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PHOTOREFRACTIVE CORNEAL ABLATION | 2014 |
|
RU2578388C1 |
| METHOD FOR ASSESSING PHOTOPROTECTIVE CORNEAL PROPERTIES | 2015 |
|
RU2581951C1 |
| METHOD FOR ASSESSING TOLERANCE OF MEDICATIONS DURING EPIBULBAR USE THEREOF | 2015 |
|
RU2604711C1 |
| METHOD OF TREATING KERATOCONUS, INCLUDING IN PATIENTS WITH CORNEAL THICKNESS OF LESS THAN 450 MICRONS, USING ULTRAVIOLET CROSS-LINKING OF CORNEAL COLLAGEN IN COMBINATION WITH PERSONALIZED TRANSEPITHELIAL PHOTOREFRACTIVE KERATECTOMY | 2023 |
|
RU2814093C1 |
| CORNEAL CROSSLINKING METHOD | 2021 |
|
RU2822101C2 |
| METHOD OF CORRECTING AMETROPIA IN PATIENTS WITH STAGE I KERATOCONUS | 2023 |
|
RU2801483C1 |
| METHOD FOR RESTORATION OF VISUAL FUNCTIONS IN PATIENTS WITH MILD MYOPIA COMBINED WITH CORNEAL KERATOCONUS | 2022 |
|
RU2820962C2 |
| METHOD FOR RESTORATION OF VISUAL FUNCTIONS IN PATIENTS WITH RESIDUAL MYOPIA AND CORNEAL FIBROPLASIA AFTER PHOTOREFRACTIVE KERATECTOMY USING FEMTOSECOND LENTICULE EXTRACTION THROUGH A SMALL ACCESS | 2021 |
|
RU2759236C1 |
| METHOD OF SURGICAL CORRECTION OF HYPERMETROPIA AND HYPERMETROPIC ASTIGMIA ON THIN CORNEA IN CHILDREN WITH ANISOMETROPIA | 2007 |
|
RU2363432C2 |
| METHOD FOR AFTER-CORRECTING RESIDUAL MYOPIC AMETROPIA AFTER PREVIOUS KERATOREFRACTIVE OPERATIONS | 2022 |
|
RU2786592C1 |
